Respiri Limited
Samaneh Sarraf is the Chief Research Officer at Respiri Limited. Prior to that, Samaneh worked at SagaTech Electronics Inc as a Research and Development Engineer. Samaneh started their career as a Research Intern at the University of Manitoba while pursuing their PhD in Biomedical Engineering, which Samaneh completed in 2014. Samaneh also holds a Master's and Bachelor's degree in Biomedical Engineering from Amirkabir University of Technology - Tehran Polytechnic.
This person is not in any teams
Respiri Limited
An RPM Business Augmented by R&D Respiri Limited (ASX:RSH, OTCQB:RSHUF) is a pioneering presence in the Remote Patient Monitoring (RPM) and MedTech sectors. The company uses its innovative respiratory technology with a disruptive business model as an RPM provider to offer the only RPM program for respiratory disorders. As a differentiated RPM provider, Respiri’s mission is to improve health outcomes for patients with chronic diseases from cardiovascular, diabetes, obesity and, exclusively, respiratory disease. Respiri’s globally unique medical device and its Remote Patient Monitoring services empower healthcare organisations to take action from patient data when needed, not only when scheduled. Respiri is strategically positioned to revolutionise chronic disease management globally and is focused on the US market, where RPM services are reimbursed by Current Procedural Terminology (CPT) Code reimbursement.